Introduction
XL147 - CAS 956958-53-5
Catalog number: B0084-258924 Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula C21H16N6O2S2
Molecular Weight 448.52
COA Inquire
Targets PI3K
Description Pilaralisib is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family of lipid kinases. It is a pyrimidine derivatives compound discovered by Exelixis Inc. It has potential antineoplastic activity. It binds to class 1 PI3Ks in an ATP-competitive manner by inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and inhibiting the activation of the PI3K signaling pathway.
Catalog number: B0084-258924 Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula C21H16N6O2S2
Molecular Weight 448.52
COA Inquire
Targets PI3K
Description Pilaralisib is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family of lipid kinases. It is a pyrimidine derivatives compound discovered by Exelixis Inc. It has potential antineoplastic activity. It binds to class 1 PI3Ks in an ATP-competitive manner by inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and inhibiting the activation of the PI3K signaling pathway.
Contact Info
Address:
45-16 Ramsey Road, Shirley, NY 11967, USA
Shirley, NY
NY 11967
United States
Shirley, NY
NY 11967
United States
Tel:
Website:
https://www.bocsci.com/xl147-cas-956958-53-5-item-258924.html
Hours of operation
| From | To | From | To | From | To | ||
|---|---|---|---|---|---|---|---|
| Monday | Open | ||||||
| Tuesday | Open | ||||||
| Wednesday | Open | ||||||
| Thursday | Open | ||||||
| Friday | Open | ||||||
| Saturday | Open | ||||||
| Sunday | Open | ||||||
